Portfolio company
Endogene.Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a biological data platform using menstrual blood to provide diagnostics and patient stratification tools for pharmaceutical firms and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Endometrics
Endometrics develops non-invasive diagnostic tests using menstrual blood samples and genomic biomarkers to detect endometriosis for women and healthcare providers.
Genie
This company develops non-invasive diagnostics using menstrual blood to study uterine molecular biomarkers for patients experiencing infertility.
Afynia
This company develops non-invasive blood tests to diagnose endometriosis for women and fertility clinics.
Metri
This biotechnology company develops organoid-based human models to create therapeutics for patients with uterine and endometrial diseases.
XELLA HEALTH
This company develops an artificial intelligence platform providing multi-omic health testing and telehealth services for women to screen for female-specific medical conditions.
Unravel Health
This company develops a palm-sized device for monitoring multiple hormones from saliva samples at home for women and clinical research partners.
Emm
This company develops a smart menstrual cup with integrated sensors that tracks flow and cycle data for people who menstruate.
Restoration Medicine
This company provides an AI-enabled pelvic health diagnostic and virtual care platform for patients with pelvic floor dysfunction and chronic pain.
